Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Inflammation Precedes Paradoxical Reactions in HIV-Negative Patients With Pulmonary Tuberculosis. Local targets link to admitted publications; unresolved targets remain external evidence.
Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV-negative patients
10.1007/s15010-012-0376-9 · 2013 · External reference
Paradoxical reactions and immune reconstitution inflammatory syndrome in tuberculosis
10.1016/j.ijid.2014.12.030 · 2015 · External reference
Paradoxical reaction in HIV negative tuberculous meningitis
10.1016/j.jns.2014.03.025 · 2014 · External reference
Clinical Spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients
10.1007/s10096-002-0821-2 · 2002 · External reference
Interleukin-1 receptor antagonist anakinra as treatment for paradoxical responses in HIV-negative tuberculosis patients: a case series
10.1016/j.medj.2022.07.001 · 2022 · External reference
Tumor necrosis factor antagonists for paradoxical inflammatory reactions in the central nervous system tuberculosis
10.1097/md.0000000000022626 · 2020 · External reference
Incidence of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and impact on patient outcome
10.1371/journal.pone.0084585 · 2013 · External reference
Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome
10.1093/cid/cis899 · 2013 · External reference
Unresolved reference
External reference
Model-based prediction of critical illness in hospitalized patients with COVID-19
10.1148/radiol.2020202723 · 2021 · External reference
Population pharmacokinetics and limited sampling strategy for first-line tuberculosis drugs and moxifloxacin
10.1016/j.ijantimicag.2014.04.019 · 2014 · External reference
Linezolid-based regimens for multidrug-resistant tuberculosis (TB): a systematic review to establish or revise the current recommended dose for TB treatment
10.1093/cid/ciy625 · 2018 · External reference
Unresolved reference
External reference
Increased bactericidal activity but dose-limiting intolerability at 50 mg·kg−1 rifampicin
10.1183/13993003.00955-2020 · 2021 · External reference
Paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pulmonary tuberculosis
2007 · External reference
Paradoxical reaction during tuberculosis treatment in HIV-seronegative patients
10.1086/500459 · 2006 · External reference
IL-1β/IL-6/CRP and IL-18/ferritin: distinct inflammatory programs in infections
10.1371/journal.ppat.1005973 · 2016 · External reference
Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients
10.1007/s10096-003-0998-z · 2003 · External reference
Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation
10.1084/jem.167.3.1211 · 1988 · External reference
Prediction model for death in patients with pulmonary tuberculosis accompanied by respiratory failure in ICU: retrospective study
10.21037/apm-20-182 · 2020 · External reference
Influence of age, IGRA results, and inflammatory markers on mortality in hospitalized tuberculosis patients
10.1016/j.jiac.2023.09.011 · 2024 · External reference
Lymph node tuberculosis: a comparison of various methods of treatment
10.1016/0041-3879(77)90041-1 · 1977 · External reference
Immune evasion and provocation by Mycobacterium tuberculosis
10.1038/s41579-022-00763-4 · 2022 · External reference
Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes
10.1183/13993003.02263-2021 · 2022 · External reference
Tuberculosis-associated hemophagocytic lymphohistiocytosis: diagnostic challenges and determinants of outcome
10.1093/ofid/ofad697 · 2024 · External reference
Pharmacokinetics of pyrazinamide and optimal dosing regimens for drug-sensitive and -resistant tuberculosis
10.1128/aac.00490-17 · 2017 · External reference
The treatment of tuberculosis
10.1002/cpt.2261 · 2021 · External reference
Fourteen-day PET/CT imaging to monitor drug combination activity in treated individuals with tuberculosis
10.1126/scitranslmed.abd7618 · 2021 · External reference
Perplexing paradoxical reactions: navigating the complexity of protracted tuberculosis meningitis—a case report
10.3389/fimmu.2024.1441945 · 2024 · External reference
